Regeneron asks FDA for emergency authorization of its Covid-19 antibody therapy given to Trump last week

Upworthy

08 Oct 2020 0 shares 1 views

Regeneron asks FDA for emergency authorization of its Covid-19 antibody therapy given to Trump last week

Regeneron asks FDA for emergency authorization of its Covid-19 antibody therapy given to Trump last week

Upworthy

Published 08 Oct 2020

Regeneron says it has applied to the US Food and Drug Administration for emergency use authorization for its experimental monoclonal...

You might like

Related news coverage

Can You Get The 'Antibody Cocktail' The President Got For COVID?

Can You Get The 'Antibody Cocktail' The President Got For COVID?

Newsy 09 Oct 2020

Watch VideoMonoclonal antibodies or “antibody cocktails” are getting a lot of attention as the next promising treatment in the..

NA Proactive news snapshot: Binovi Technologies, Vuzix Corporation, Mineworx Technologies, PyroGenesis Canada UPDATE …
Proactive Investors 22 Oct 2020
NA Proactive news snapshot: Loop Insights, Altamira Gold, Avalon GloboCare, Todos Medical, Lexaria Bioscience, One World Lithium, NetCents UPDATE…
Proactive Investors 22 Oct 2020
US stocks end mixed as DJIA notches first daily gain in four sessions on strong US consumer data
Proactive Investors 16 Oct 2020
Wall Street set to snap losing streak after US retail sales jump
Proactive Investors 16 Oct 2020

Advertisement

More coverage

NA Proactive news snapshot: Agraflora Organics, Nerds On Site, Altamira Gold, American Manganese UPDATE …

Agraflora Organics International Inc (CSE:AGRA) (OCTMKTS:AGFAF) has submitted a formal response to Health Canada's first request..

Proactive Investors 02 Oct 2020

NA Proactive news snapshot: Algernon Pharmaceuticals, OTC Markets Group, Auryn Resources, NexTech AR, WeedMD, Mirasol Resources, New Pacific Metals, Media Central UPDATE...

Algernon Pharmaceuticals Inc (CSE:AGN) (OTCQB:BTHCF) announced Friday it had reached 75% enrollment for its multinational Phase..

Proactive Investors 02 Oct 2020